Sep 2026
Daratumumab in Combination With High-Dose Cytarabine and Amsacrine as an Effective Salvage Therapy and Bridge to Allogeneic Hematopoietic Stem Cell Transplantation for Refractory T-Cell Acute Lymphoblastic Leukemia: A Case Report.
The achievement of a third complete response with the combination of daratumumab, high-dose cytarabine, and amsacrine in an 11-year-old patient with highly aggressive relapsed T-ALL, enabling subsequent allogeneic hematopoietic stem cell transplantation.
Perrine Moyer, Baptiste Le Calvez, C. Mayeur-Rousse et al.
· Pediatric Blood & Cancer · 0 citations